478 related articles for article (PubMed ID: 28295288)
21. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
Ji T; Zhang X; Li W
Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
[TBL] [Abstract][Full Text] [Related]
22. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
[TBL] [Abstract][Full Text] [Related]
23. FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity.
Sunayama J; Sato A; Matsuda K; Tachibana K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
Stem Cells; 2011 Sep; 29(9):1327-37. PubMed ID: 21793107
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional activation of SIRT6 via FKHRL1/FOXO3a inhibits the Warburg effect in glioblastoma cells.
Dong Z; Zhong X; Lei Q; Chen F; Cui H
Cell Signal; 2019 Aug; 60():100-113. PubMed ID: 31004738
[TBL] [Abstract][Full Text] [Related]
26. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
[No Abstract] [Full Text] [Related]
27. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
28. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
[TBL] [Abstract][Full Text] [Related]
29. Protein phosphatase 4 catalytic subunit is overexpressed in glioma and promotes glioma cell proliferation and invasion.
Li M; Li X; Xu S; Xue P; Li Q; Lu Q; Jia Q; Zhang L; Li X; Li X
Tumour Biol; 2016 Sep; 37(9):11893-11901. PubMed ID: 27059736
[TBL] [Abstract][Full Text] [Related]
30. CXCL12-induced upregulation of FOXM1 expression promotes human glioblastoma cell invasion.
Wang S; Zhang S; Li J; Xu X; Weng Y; Zheng M; Ouyang L; Li F
Biochem Biophys Res Commun; 2014 Apr; 447(1):1-6. PubMed ID: 24561124
[TBL] [Abstract][Full Text] [Related]
31. Expression and prognostic significance of TCTN1 in human glioblastoma.
Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
[TBL] [Abstract][Full Text] [Related]
32. CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.
Ji QK; Ma JW; Liu RH; Li XS; Shen FZ; Huang LY; Hui L; Ma YJ; Jin BZ
Mol Med Rep; 2019 Aug; 20(2):1149-1156. PubMed ID: 31173217
[TBL] [Abstract][Full Text] [Related]
33. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
[TBL] [Abstract][Full Text] [Related]
34. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma.
Guo RM; Zhao CB; Li P; Zhang L; Zang SH; Yang B
ASN Neuro; 2018; 10():1759091418781949. PubMed ID: 29914265
[TBL] [Abstract][Full Text] [Related]
36. High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance.
Wu ZB; Cai L; Lin SJ; Xiong ZK; Lu JL; Mao Y; Yao Y; Zhou LF
Neuro Oncol; 2013 Sep; 15(9):1264-75. PubMed ID: 23828241
[TBL] [Abstract][Full Text] [Related]
37. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.
Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH
Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041
[TBL] [Abstract][Full Text] [Related]
38. NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2.
Wang L; Wang Z; Li J; Zhang W; Ren F; Yue W
Int J Mol Med; 2015 May; 35(5):1333-40. PubMed ID: 25738651
[TBL] [Abstract][Full Text] [Related]
39. Cytoplasmic TRADD confers a worse prognosis in glioblastoma.
Chakraborty S; Li L; Tang H; Xie Y; Puliyappadamba VT; Raisanen J; Burma S; Boothman DA; Cochran B; Wu J; Habib AA
Neoplasia; 2013 Aug; 15(8):888-97. PubMed ID: 23908590
[TBL] [Abstract][Full Text] [Related]
40. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.
Kim CK; Nguyen TL; Joo KM; Nam DH; Park J; Lee KH; Cho SW; Ahn JY
Cancer Res; 2010 Dec; 70(23):9730-41. PubMed ID: 21098709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
